EMD Millipore Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations
Go back to EMD Millipore Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations| Merck KGaA Unsponsored ADR (AMEX: MKGAY) | Delayed: 38.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.36 | 52 Week High | $37.16 | |||
| Open | $0.30 | 52 Week Low | $26.91 | |||
| Day High | $38.36 | P/E | N/A | |||
| Day Low | $38.36 | EPS | $0.00 | |||
| Volume | 129,873 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 149.50 +2.63 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.87 | 52 Week High | $65.46 | |||
| Open | $146.79 | 52 Week Low | $47.97 | |||
| Day High | $150.49 | P/E | 101.70 | |||
| Day Low | $145.60 | EPS | $1.47 | |||
| Volume | 7,996,283 | |||||
